Silencing efficiency differs among tissues and endogenous microRNA pathway is preserved in short hairpin RNA transgenic mice

FEBS Letters

Volumn 583, Issue 1, 2009, Pages 213-218

  Sasaguri, Hiroki ^a   Mitani, Tasuku ^b   Anzai, Masayuki ^b   Kubodera, Takayuki ^a   Saito, Yuki ^a   Yamada, Hiromi ^a   Mizusawa, Hidehiro ^a   Yokota, Takanori ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b KINKI UNIVERSITY   (Japan)

Author keywords

MicroRNA; Oversaturation; RNA interference; Short hairpin RNA; Small interfering RNA; Transgenic mice

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; MICRORNA; SHORT HAIRPIN RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; FEMALE; GENE SILENCING; GENETIC ANALYSIS; LIVER; LIVER CELL; LUNG; MALE; MOUSE; MUSCLE CELL; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; TRANSGENIC MOUSE;

ANIMALS; CEREBRUM; GENE SILENCING; MICE; MICE, TRANSGENIC; MICRORNAS; NUCLEIC ACID CONFORMATION; SUPEROXIDE DISMUTASE;

MUS; MUS MUSCULUS;

EID: 57749197167     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2008.12.012     Document Type: Article

References (22)

1. Hannon G.J. RNA interference. Nature 418 (2002) 244-251
2. Dykxhoorn D.M., and Lieberman J. The silent revolution: RNA interference as basic biology, research tool, and therapeutic. Annu. Rev. Med. 56 (2005) 401-423
3. Grimm D., and Kay M.A. Therapeutic application of RNAi: is mRNA targeting finally ready for prime time?. J. Clin. Invest. 117 (2007) 3633-3641
4. Gao X., and Zhang P. Transgenic RNA interference in mice. Physiology 22 (2007) 161-166
5. Coumoul X., and Deng C.X. RNAi in mice: a promising approach to decipher gene functions in vivo. Biochimie 88 (2006) 637-643
6. Kunath T., Gish G., Lickert H., Jones N., Pawson T., and Rossant J. Transgenic RNA interference in ES cell-derived embryos recapitulates a genetic null phenotype. Nat. Biotechnol. 21 (2003) 559-561
7. Xia X.G., Zhou H., Samper E., Melov S., and Xu Z. Pol II-expressed shRNA knocks down Sod2 gene expression and causes phenotypes of the gene knockout in mice. PLoS Genet. 2 (2006) e10
8. Rossi J.J. Expression strategies for short hairpin RNA interference triggers. Hum. Gene Ther. 19 (2008) 313-317
9. Grimm D., Streetz K.L., Jopling C.L., Storm T.A., Pandey K., Davis C.R., Marion P., Salazar F., and Kay M.A. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 441 (2006) 537-541
10. Castanotto D., Sakurai K., Lingeman R., Li H., Shively L., Aagaard L., Soifer H., Gatignol A., Riggs A., and Rossi J.J. Combinatorial delivery of small interfering RNAs reduces RNAi efficacy by selective incorporation into RISC. Nucleic Acids Res. 35 (2007) 5154-5164
11. Saito Y., Yokota T., Mitani T., Ito K., Anzai M., Miyagishi M., Taira K., and Mizusawa H. Transgenic small interfering RNA halts amyotrophic lateral sclerosis in a mouse model. J. Biol. Chem. 280 (2005) 42826-42830
12. Yokota T., Miyagishi M., Hino T., Matsumura R., Tasinato A., Urushitani M., Rao R.V., Takahashi R., Bredesen D.E., Taira K., and Mizusawa H. siRNA-based inhibition specific for mutant SOD1 with single nucleotide alternation in familial ALS, compared with ribozyme and DNA enzyme. Biochem. Biophys. Res. Commun. 314 (2004) 283-291
13. Ando Y., Liang Y., Ishigaki S., Niwa J., Jiang Y., Kobayashi Y., Yamamoto M., Doyu M., and Sobue G. Caspase-1 and -3 mRNAs are differentially upregulated in motor neurons and glial cells in mutant SOD1 transgenic mouse spinal cord: a study using laser microdissection and real-time RT-PCR. Neurochem. Res. 28 (2003) 839-846
14. Tateno M., Sadakata H., Tanaka M., Itohara S., Shin R.M., Miura M., Masuda M., Aosaki T., Urushitani M., Misawa H., and Takahashi R. Calcium-permeable AMPA receptors promote misfolding of mutant SOD1 protein and development of amyotrophic lateral sclerosis in a transgenic mouse model. Hum. Mol. Genet. 13 (2004) 2183-2196
15. Uchiyama S., Shimizu T., and Shirasawa T. CuZn-SOD deficiency causes ApoB degradation and induces hepatic lipid accumulation by impaired lipoprotein secretion in mice. J. Biol. Chem. 281 (2006) 31713-31719
16. Matzuk M.M., Dionne L., Guo Q., Kumar T.R., and Lebovitz R.M. Ovarian function in superoxide dismutase 1 and 2 knockout mice. Endocrinology 139 (1998) 4008-4011
17. Meister G., Landthaler M., Patkaniowska A., Dorsett Y., Teng G., and Tuschl T. Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol. Cell 15 (2004) 185-197
18. González-González E., López-Casas P.P., and del Mazo J. The expression patterns of genes involved in the RNAi pathways are tissue-dependent and differ in the germ and somatic cells of mouse testis. Biochim. Biophys. Acta 1779 (2008) 306-311
19. Sago N., Omi K., Tamura Y., Kunugi H., Toyo-oka T., Tokunaga K., and Hohjoh H. RNAi induction and activation in mammalian muscle cells where Dicer and eIF2C translation initiation factors are barely expressed. Biochem. Biophys. Res. Commun. 319 (2004) 50-57
20. Johnson S.M., Grosshans H., Shingara J., Byrom M., Jarvis R., Cheng A., Labourier E., Reinert K.L., Brown D., and Slack F.J. RAS is regulated by the let-7 microRNA family. Cell 120 (2005) 635-647
21. Sampson V.B., Rong N.H., Han J., Yang Q., Aris V., Soteropoulos P., Petrelli N.J., Dunn S.P., and Krueger L.J. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res. 67 (2007) 9762-9770
22. McBride J.L., Boudreau R.L., Harper S.Q., Staber P.D., Monteys A.M., Martins I., Gilmore B.L., Burstein H., Peluso R.W., Polisky B., Carter B.J., and Davidson B.L. Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. Proc. Natl. Acad. Sci. USA 105 (2008) 5868-5873